Top

Published in:

Open Access 01-01-2020 | Peri-Implant Diseases in the Maxillofacial Region | Original Article

CSF-1 and IL-34 levels in peri-implant crevicular fluid and saliva from patients having peri-implant diseases

Authors: Ronaldo Lira-Junior, Mayla K. S. Teixeira, Eduardo J. V. Lourenço, Daniel M. Telles, Carlos Marcelo Figueredo, Elisabeth A. Boström

Published in: Clinical Oral Investigations | Issue 1/2020

Abstract

Objective

Colony-stimulating factor (CSF)-1 and interleukin (IL)-34 are growth factors that regulate myeloid cell functions and support osteoclastogenesis. CSF-1 and IL-34 levels in peri-implant diseases are yet unknown. This study evaluated CSF-1, IL-34, and IL-1β levels in saliva and peri-implant crevicular fluid (PICF) from patients having mucositis or peri-implantitis, as well as their correlation to clinical parameters of disease.

Material and methods

Forty-three patients were included (mean age 61.1 ± 8.4; 62.8% female), 20 having mucositis and 23 having peri-implantitis. Patients were clinically examined and unstimulated whole saliva and PICF were collected. Levels of CSF-1, IL-34, and IL-1β were determined by enzyme-linked immunosorbent assays.

Results

CSF-1 levels were higher in PICF from peri-implantitis compared with mucositis patients (p = 0.028), whereas IL-34 levels showed no significant difference between the groups (p = 0.060). No significant difference was found in PICF IL-1β levels between the groups. Salivary levels of CSF-1 and IL-34 did not differ significantly between mucositis and peri-implantitis. No significant difference was observed in the salivary levels of IL-1β between groups (p = 0.061). CSF-1 and IL-1β correlated significantly in both saliva and PICF. CSF-1 levels in saliva correlated with its levels in PICF. PICF CSF-1 levels showed potential to discriminate between peri-implantitis and mucositis (AUC = 0.695, 95% CI 0.53–0.85; p = 0.029).

Conclusion

Increased levels of CSF-1 in peri-implant crevicular fluid, but not in saliva, were found in peri-implantitis patients, which might aid to discriminate the early and late stages of peri-implant diseases.

Clinical relevance

This result suggests an increased osteoclastogenic potential in peri-implantitis patients.

Lee CT, Huang YW, Zhu L, Weltman R (2017) Prevalences of peri-implantitis and peri-implant mucositis: systematic review and meta-analysis. J Dent 62:1–12. https://doi.org/10.1016/j.jdent.2017.04.011 CrossRefPubMed

Zitzmann NU, Berglundh T (2008) Definition and prevalence of peri-implant diseases. J Clin Periodontol 35:286–291. https://doi.org/10.1111/j.1600-051X.2008.01274.x CrossRefPubMed

Heitz-Mayfield LJ, Lang NP (2010) Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000 53:167–181. https://doi.org/10.1111/j.1600-0757.2010.00348.x CrossRefPubMed

Nguyen Vo TN, Hao J, Chou J, Oshima M, Aoki K, Kuroda S, Kaboosaya B, Kasugai S (2017) Ligature induced peri-implantitis: tissue destruction and inflammatory progression in a murine model. Clin Oral Implants Res 28:129–136. https://doi.org/10.1111/clr.12770 CrossRefPubMed

Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14:628–638. https://doi.org/10.1016/j.tcb.2004.09.016 CrossRefPubMed

Campbell IK, Rich MJ, Bischof RJ, Hamilton JA (2000) The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol 68:144–150PubMed

Marshall D, Cameron J, Lightwood D, Lawson AD (2007) Blockade of colony stimulating factor-1 (CSF-I) leads to inhibition of DSS-induced colitis. Inflamm Bowel Dis 13:219–224. https://doi.org/10.1002/ibd.20055 CrossRefPubMed

Kimura K, Kitaura H, Fujii T, Ishida M, Hakami ZW, Takano-Yamamoto T (2014) An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model. Oral Dis 20:319–324. https://doi.org/10.1111/odi.12117 CrossRefPubMed

Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, Halenbeck R, Wu G, Zhou A, Behrens D, Hollenbaugh D, Linnemann T, Qin M, Wong J, Chu K, Doberstein SK, Williams LT (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320:807–811. https://doi.org/10.1126/science.1154370 CrossRefPubMed

10.

Guillonneau C, Bezie S, Anegon I (2017) Immunoregulatory properties of the cytokine IL-34. Cell Mol Life Sci 74:2569–2586. https://doi.org/10.1007/s00018-017-2482-4 CrossRefPubMed

11.

Bostrom EA, Lundberg P (2013) The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. PLoS One 8:e81665. https://doi.org/10.1371/journal.pone.0081665 CrossRefPubMedPubMedCentral

12.

Lira-Junior R, Akerman S, Gustafsson A, Klinge B, Bostrom EA (2017) Colony stimulating factor-1 in saliva in relation to age, smoking, and oral and systemic diseases. Sci Rep 7:7280. https://doi.org/10.1038/s41598-017-07698-4 CrossRefPubMedPubMedCentral

13.

Martinez GL, Majster M, Bjurshammar N, Johannsen A, Figueredo CM, Bostrom EA (2017) Salivary colony stimulating factor-1 and interleukin-34 in periodontal disease. J Periodontol 88:e140–e149. https://doi.org/10.1902/jop.2017.170081 CrossRefPubMed

14.

Petkovic AB, Matic SM, Stamatovic NV, Vojvodic DV, Todorovic TM, Lazic ZR, Kozomara RJ (2010) Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 39:478–485. https://doi.org/10.1016/j.ijom.2010.01.014 CrossRefPubMed

15.

Zani SR, Moss K, Shibli JA, Teixeira ER, de Oliveira Mairink R, Onuma T, Feres M, Teles RP (2016) Peri-implant crevicular fluid biomarkers as discriminants of peri-implant health and disease. J Clin Periodontol 43:825–832. https://doi.org/10.1111/jcpe.12586 CrossRefPubMed

16.

Faot F, Nascimento GG, Bielemann AM, Campao TD, Leite FR, Quirynen M (2015) Can peri-implant crevicular fluid assist in the diagnosis of peri-implantitis? A systematic review and meta-analysis. J Periodontol 86:631–645. https://doi.org/10.1902/jop.2015.140603 CrossRefPubMed

17.

Teixeira MKS, Lira-Junior R, Telles DM, Lourenco EJV, Figueredo CM (2017) Th17-related cytokines in mucositis: is there any difference between peri-implantitis and periodontitis patients? Clin Oral Implants Res 28:816–822. https://doi.org/10.1111/clr.12886 CrossRefPubMed

18.

Lindhe J, Meyle J, Group D of European Workshop on Periodontology (2008) Peri-implant diseases: consensus report of the sixth European workshop on periodontology. J Clin Periodontol 35:282–285. https://doi.org/10.1111/j.1600-051X.2008.01283.x CrossRefPubMed

19.

American Academy of Periodontology (2013) Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol 84:436–443. https://doi.org/10.1902/jop.2013.134001 CrossRef

20.

Loe H, Silness J (1963) Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21:533–551CrossRef

21.

Pontoriero R, Tonetti MP, Carnevale G, Mombelli A, Nyman SR, Lang NP (1994) Experimentally induced peri-implant mucositis. A clinical study in humans. Clin Oral Implants Res 5:254–259CrossRef

22.

Guruprasad CN, Pradeep AR (2018) Interleukin-34 levels in gingival crevicular fluid and plasma in periodontal health and disease with and without type-2 diabetes mellitus. J Investig Clin Dent 9:e12317. https://doi.org/10.1111/jicd.12317 CrossRefPubMed

23.

Guruprasad CN, Pradeep AR (2018) Effect of nonsurgical periodontal therapy on interleukin-34 levels in periodontal health and disease. Indian J Dent Res 29:280–285. https://doi.org/10.4103/ijdr.IJDR_527_17 CrossRefPubMed

24.

Zhang L, Cui M, Ding L, Xia L, Lu J, Shen H (2018) Interleukin-34 aggravates the severity of arthritis in collagen-induced arthritis mice by inducing interleukin-17 production. J Interf Cytokine Res 38:221–225. https://doi.org/10.1089/jir.2017.0095 CrossRef

25.

Zwicker S, Martinez GL, Bosma M, Gerling M, Clark R, Majster M, Soderman J, Almer S, Bostrom EA (2015) Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin Sci (Lond) 129:281–290. https://doi.org/10.1042/CS20150176 CrossRef

26.

Chang SH, Choi BY, Choi J, Yoo JJ, Ha YJ, Cho HJ, Kang EH, Song YW, Lee YJ (2015) Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis. Rheumatol Int 35:71–79. https://doi.org/10.1007/s00296-014-3056-5 CrossRefPubMed

27.

Nakamichi Y, Udagawa N, Takahashi N (2013) IL-34 and CSF-1: similarities and differences. J Bone Miner Metab 31:486–495. https://doi.org/10.1007/s00774-013-0476-3 CrossRefPubMed

28.

Al-Askar M, Ajlan S, Alomar N, Al-Daghri NM (2018) Clinical and radiographic peri-implant parameters and whole salivary interleukin-1beta and interleukin-6 levels among type-2 diabetic and nondiabetic patients with and without peri-implantitis. Med Princ Pract 27:133–138. https://doi.org/10.1159/000488032 CrossRefPubMedPubMedCentral

29.

Fonseca FJ, Moraes Junior M, Lourenco EJ, Teles Dde M, Figueredo CM (2014) Cytokines expression in saliva and peri-implant crevicular fluid of patients with peri-implant disease. Clin Oral Implants Res 25:e68–e72. https://doi.org/10.1111/clr.12052 CrossRefPubMed

Title: CSF-1 and IL-34 levels in peri-implant crevicular fluid and saliva from patients having peri-implant diseases
Authors: Ronaldo Lira-Junior
Mayla K. S. Teixeira
Eduardo J. V. Lourenço
Daniel M. Telles
Carlos Marcelo Figueredo
Elisabeth A. Boström
Publication date: 01-01-2020
Publisher: Springer Berlin Heidelberg
Keywords: Peri-Implant Diseases in the Maxillofacial Region
Bleeding on Probing
Published in: Clinical Oral Investigations / Issue 1/2020
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-019-02935-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

CSF-1 and IL-34 levels in peri-implant crevicular fluid and saliva from patients having peri-implant diseases

Abstract

Objective

Material and methods

Results

Conclusion

Clinical relevance

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Material and methods

Results

Conclusion

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 1/2020

Assessment of early discomfort and wound healing outcomes after periodontal surgery with and without enamel matrix derivative: an observational retrospective case-control study

In vitro evaluation of the cariogenic potential of rebaudioside A compared to sucrose and xylitol

Apical periodontitis as potential source of infection in patients with lymphoma treated with chemotherapy

A chitosan-based irrigant improves the dislocation resistance of a mineral trioxide aggregate-resin hybrid root canal sealer

Systemic and periodontal conditions of overweight/obese patients during pregnancy and after delivery: a prospective cohort

Oral health–related quality of life in different clinical forms of oral lichen planus